ENDOCRINE CORE SERVICES
内分泌核心服务
基本信息
- 批准号:7715570
- 负责人:
- 金额:$ 2.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AndrogensBioavailableBiological AssayCarrier ProteinsCellsChorionic GonadotropinComputer Retrieval of Information on Scientific Projects DatabaseDetectionElectromagneticsEndocrineEstrogensFacultyFecesFundingGrantHigh Pressure Liquid ChromatographyHormonesHousingIndividualInstitutionLuteinizing HormoneMacacaMeasurementMetabolicMonkeysPlasmaResearchResearch PersonnelResourcesSalivaScientistServicesSourceTherapeutic Human ExperimentationThyroid GlandUnited States National Institutes of HealthUrineassay developmentbasemonoaminesteroid hormone
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Objective: The Endocrine Core has provided assays for twenty-two scientists, and recharged approximately $166,000. Our assays include routine analysis of steroid hormones in plasma, feces, urine and saliva and unique analyses that are not available elsewhere. Similarly, its assay development is directed towards providing assays that are used by our faculty and collaborators but are not readily available to them. During the past year the Endocrine Core has extended its service to include metabolic hormones and carrier proteins. It is our intent to provide in-house service for all assays requested through Therapeutics, Research Services and by individual investigators. Some of the new assays are being formatted on the ACS-180 automated chemiluminescence platform. A macaque thyroid panel as well as monkey chorionic gonadotropin (mCG) assays are now available. New cell based bioassays now provide direct measurements of circulating bioavailable estrogens, androgens and luteinizing hormone. HPLC with electromagnetic detection is being developed for assay of monoamines.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
目的:内分泌核心中心已经为22名科学家提供了化验,并充值了大约166,000美元。我们的分析包括对血浆、粪便、尿液和唾液中类固醇激素的常规分析,以及其他地方没有的独特分析。同样,它的化验开发旨在提供供我们的教职员工和合作者使用但他们不容易获得的化验。在过去的一年里,内分泌核心扩大了它的服务范围,包括代谢激素和载体蛋白。我们的意图是为所有通过治疗、研究服务和个人调查人员要求的分析提供内部服务。一些新的分析方法正在ACS-180自动化学发光平台上格式化。猕猴甲状腺仪表板和猕猴绒毛膜促性腺激素(MCG)检测现已推出。新的基于细胞的生物测定现在提供了循环中生物可用雌激素、雄激素和黄体生成素的直接测量。电磁检测的高效液相色谱技术正在被开发用于单胺类化合物的检测。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bill Lee Lasley其他文献
Bill Lee Lasley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bill Lee Lasley', 18)}}的其他基金
INVESTIGATIONS OF A NEW TYPE ENDOCRINE DISRUPTOR, TCC
新型内分泌干扰物 TCC 的研究
- 批准号:
8357287 - 财政年份:2011
- 资助金额:
$ 2.71万 - 项目类别:
ADAPTING MICROTITERPLATE ASSAYS TO AN AUTOMATED PLATFORM
将微量滴定板测定调整至自动化平台
- 批准号:
8357262 - 财政年份:2011
- 资助金额:
$ 2.71万 - 项目类别:
INVESTIGATIONS OF A NEW TYPE ENDOCRINE DISRUPTOR, TCC
新型内分泌干扰物 TCC 的研究
- 批准号:
8172562 - 财政年份:2010
- 资助金额:
$ 2.71万 - 项目类别:
Exploration of the endocrine disrupting effects of triclocarban
三氯卡班的内分泌干扰作用探讨
- 批准号:
8004105 - 财政年份:2010
- 资助金额:
$ 2.71万 - 项目类别:
Exploration of the endocrine disrupting effects of triclocarban
三氯卡班的内分泌干扰作用探讨
- 批准号:
7787864 - 财政年份:2010
- 资助金额:
$ 2.71万 - 项目类别:
ADAPTING MICROTITERPLATE ASSAYS TO AN AUTOMATED PLATFORM
将微量滴定板测定调整至自动化平台
- 批准号:
8172532 - 财政年份:2010
- 资助金额:
$ 2.71万 - 项目类别:
ADAPTING MICROTITERPLATE ASSAYS TO AN AUTOMATED PLATFORM
将微量滴定板测定调整至自动化平台
- 批准号:
7959015 - 财政年份:2009
- 资助金额:
$ 2.71万 - 项目类别:
INVESTIGATIONS OF A NEW TYPE ENDOCRINE DISRUPTOR, TCC
新型内分泌干扰物 TCC 的研究
- 批准号:
7959062 - 财政年份:2009
- 资助金额:
$ 2.71万 - 项目类别:
ADAPTING MICROTITERPLATE ASSAYS TO AN AUTOMATED PLATFORM
将微量滴定板测定调整至自动化平台
- 批准号:
7715601 - 财政年份:2008
- 资助金额:
$ 2.71万 - 项目类别:
ADAPTING MICROTITERPLATE ASSAYS TO AN AUTOMATED PLATFORM
将微量滴定板测定调整至自动化平台
- 批准号:
7562192 - 财政年份:2007
- 资助金额:
$ 2.71万 - 项目类别:
相似海外基金
ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines
ASD3MAP:非晶固体分散体数字设计和制造平台,用于快速、资源高效地开发生物可利用药物
- 批准号:
10078996 - 财政年份:2023
- 资助金额:
$ 2.71万 - 项目类别:
Collaborative R&D
Collaborative Research: Mineral-associated organic matter: an overlooked source and mediator of bioavailable nitrogen
合作研究:矿物相关有机物:被忽视的生物可利用氮的来源和介质
- 批准号:
2400998 - 财政年份:2023
- 资助金额:
$ 2.71万 - 项目类别:
Standard Grant
Preclinical development of highly potent and orally bioavailable PCSK9 inhibitors for patients at high cardiovascular risk
针对高心血管风险患者的高效口服 PCSK9 抑制剂的临床前开发
- 批准号:
494266 - 财政年份:2023
- 资助金额:
$ 2.71万 - 项目类别:
Operating Grants
Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections
用于治疗 COVID-19 和其他人类冠状病毒感染的口服生物可利用抑制剂的优化
- 批准号:
10698831 - 财政年份:2023
- 资助金额:
$ 2.71万 - 项目类别:
Investigational New Drug (IND)-enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.
用于治疗酒精使用障碍的选择性、可逆、口服生物可利用的 ALDH2 抑制剂 ANS-00858 的研究性新药 (IND) 启用和早期开发。
- 批准号:
10748087 - 财政年份:2023
- 资助金额:
$ 2.71万 - 项目类别:
Project 1 – Development of Orally Bioavailable beta-CoV Inhibitors
项目 1 — 口服生物可利用的 β-CoV 抑制剂的开发
- 批准号:
10513942 - 财政年份:2022
- 资助金额:
$ 2.71万 - 项目类别:
Making peptides orally bioavailable
使肽具有口服生物利用度
- 批准号:
DP220103549 - 财政年份:2022
- 资助金额:
$ 2.71万 - 项目类别:
Discovery Projects
Collaborative Research: Mineral-associated organic matter: an overlooked source and mediator of bioavailable nitrogen
合作研究:矿物相关有机物:被忽视的生物可利用氮的来源和介质
- 批准号:
2103187 - 财政年份:2021
- 资助金额:
$ 2.71万 - 项目类别:
Standard Grant
Collaborative Research: Mineral-associated organic matter: An overlooked source and mediator of bioavailable nitrogen
合作研究:矿物相关有机物:被忽视的生物可利用氮的来源和介质
- 批准号:
2103076 - 财政年份:2021
- 资助金额:
$ 2.71万 - 项目类别:
Standard Grant
A first-in-class orally bioavailable small molecule dual inhibitor targeting NLRP3 and the dopamine transporter to treat AD
首创的口服生物可利用小分子双重抑制剂,靶向 NLRP3 和多巴胺转运蛋白,用于治疗 AD
- 批准号:
10325722 - 财政年份:2021
- 资助金额:
$ 2.71万 - 项目类别:














{{item.name}}会员




